Metabolic Risk Factors of Developing Liver Steatosis among Patients with Chronic Hepatitis B: A National Cohort from Romania
Journal of Gastrointestinal and Liver Diseases · 2026
DOI: 10.15403/jgld-7192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, 2026. Verfasst von Anca Trifan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, Iasi; St. Spiridon Emergency Hospital, Institute of Gastroentero…. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Fatty Liver. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims: The coexistence of liver steatosis in patients with chronic viral hepatitis B (CHB) is growing relevant as the global epidemic of obesity and type 2 diabetes mellitus (T2DM). The aim of this study was to identify the metabolic risk factors linked to steatotic liver disease (SLD) in Romanian patients with CHB.
Methods
In this prospective study, we evaluated 320,000 individuals in the LIVE(RO)2 nationwide screening program in Romania from 2021 to 2023. The majority of the patients had undergone transient elastography using controlled attenuation parameter (CAP) to diagnose liver steatosis, and they belonged to vulnerable categories. Exclusion criteria included heavy alcohol consumption, any other liver disease unrelated to CHB, and the lack of CAP evaluation.
Results
5,321 individuals (1.67%) were found with CHB in the screening program. In the final analysis we included 1,970 patients, with a mean age of 55.87±13.84 years; 57.9% of them were males, with a mean body mass index (BMI) level of 27.26 kg/m², and 61.9% of the patients were vulnerable. The prevalence of SLD was 42.2% in the group of vulnerable individuals, compared with non-vulnerable participants, who had a prevalence of SLD of 26.4%. Moreover, patients with vulnerable conditions have a higher prevalence of T2DM (11.5%), hypertension (41.3%), and raised BMI levels ≥25 kg/m² (71.3%). In our study, vulnerable subjects had a higher prevalence of hepatitis B virus e antigen (HBeAg) positivity of 3%, and it was found to be a protective risk factor for hepatic steatosis development (aOR=0.397). Also, these patients had a higher prevalence of severe liver fibrosis (≥ F3) of 17.1%, compared with those non-vulnerable, with a prevalence of 9.7% of severe liver fibrosis. More than that, we find that the presence of HBeAg-positive increases the risk of severe liver fibrosis progression 6 times higher.
Conclusions
In our study we found a prevalence of hepatic steatosis of 42.2% in the cohort of vulnerable untreated patients with CHB, and the prevalence of severe fibrosis was 17.1%. Presence of HBeAg-positive was found to be a protective risk factor for hepatic steatosis but accelerates the development of severe fibrosis along with T2DM, which is more common in the vulnerable CHB cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, Iasi; St. Spiridon Emergency Hospital, Institute of Gastroenterology and Hepatology, Iasi, Romania. ancatrifan@yahoo.com.
- Department of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, Iasi; St. Spiridon Emergency Hospital, Institute of Gastroenterology and Hepatology, Iasi, Romania. robertnastasa948@gmail.com.
- Department of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, Iasi; St. Spiridon Emergency Hospital, Institute of Gastroenterology and Hepatology, Iasi, Romania. stanciucarol@yahoo.com.
- Department of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, Iasi; St. Spiridon Emergency Hospital, Institute of Gastroenterology and Hepatology, Iasi, Romania. stratina.ermina@yahoo.com.
- Department of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, Iasi; St. Spiridon Emergency Hospital, Institute of Gastroenterology and Hepatology, Iasi, Romania. drcuciureanutudor@gmail.com.
- Department of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, Iasi; St. Spiridon Emergency Hospital, Institute of Gastroenterology and Hepatology, Iasi, Romania. lungu.christina@yahoo.com.
Zitieren
APA
Trifan, A., Nastasa, R., Stanciu, C., Stratina, E., Cuciureanu, T., Muzica, C. M., Zenovia, S., Stafie, R., Rotaru, A., Singeap, A. M., Girleanu, I., Huiban, L., Iacob, S., Pop, C. S., Moscalu, M., & Gheorghe, L. (2026). Metabolic Risk Factors of Developing Liver Steatosis among Patients with Chronic Hepatitis B: A National Cohort from Romania. Journal of Gastrointestinal and Liver Diseases. https://doi.org/10.15403/jgld-7192
Vancouver
Trifan A, Nastasa R, Stanciu C, Stratina E, Cuciureanu T, Muzica CM, et al. Metabolic Risk Factors of Developing Liver Steatosis among Patients with Chronic Hepatitis B: A National Cohort from Romania. Journal of Gastrointestinal and Liver Diseases. 2026. doi:10.15403/jgld-7192
BibTeX
@article{Trifan2026,
author = {Trifan, Anca and Nastasa, Robert and Stanciu, Carol and Stratina, Ermina and Cuciureanu, Tudor and Muzica, Cristina Maria and Zenovia, Sebastian and Stafie, Remus and Rotaru, Adrian and Singeap, Ana-Maria and Girleanu, Irina and Huiban, Laura and Iacob, Speranta and Pop, Corina Silvia and Moscalu, Mihaela and Gheorghe, Liana},
title = {Metabolic Risk Factors of Developing Liver Steatosis among Patients with Chronic Hepatitis B: A National Cohort from Romania},
journal = {Journal of Gastrointestinal and Liver Diseases},
year = {2026},
doi = {10.15403/jgld-7192}
}
EUVIMED